Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises NOTE in connection with the company’s underwritten rights issue
Mandate

Vinge advises NOTE in connection with the company’s underwritten rights issue

March 11, 2010

Vinge is advising NOTE AB (publ) in connection with the new issue of shares for approximately SEK 87 million with pre-emption rights for NOTE’s shareholders. The rights issue is conditional upon approval by the members at an extraordinary general meeting to be held on 7 April 2010. The new issue is fully underwritten by a subscription agreement and guarantee commitment by NOTE’s major shareholders.

NOTE is listed on NASDAQ OMX Stockholm. Note’s business concept is to provide electronics manufacturing and logistics services.

Vinge’s team consisted of Ola Sandersson, Dain Nevonen and Christian Granqvist. Bo Adrianzon is the responsible partner.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

 Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026